Familial Hypercholesterolemia Family Tree

Decoding Familial Hypercholesterolemia: A Comprehensive Guide to Diagnosis and Treatment

Author's portrait.
Lena Kashyap in Health & Wellness June 2025 • 4 min read.

"Understand the genetic roots, diagnostic pathways, and cutting-edge treatments for familial hypercholesterolemia to protect your heart health."


Familial hypercholesterolemia (FH) is an inherited condition characterized by high levels of low-density lipoprotein cholesterol (LDL-C) from birth. This relentless elevation of LDL-C, often dubbed “bad” cholesterol, dramatically increases the risk of premature atherosclerotic cardiovascular disease (ASCVD), leading to heart attacks and strokes at a young age. Understanding FH is crucial because early diagnosis and intervention can significantly alter the course of this disease.

FH arises from mutations in genes that control how the body processes cholesterol, most commonly the LDL receptor (LDLR) gene. These genetic defects impair the liver's ability to remove LDL-C from the blood, causing it to accumulate. There are two forms of FH: heterozygous FH (HeFH), where one copy of the affected gene is inherited, and homozygous FH (HoFH), where both copies are affected. HoFH is far more severe and rarer.

Despite its prevalence—affecting as many as 1 in 300 people—FH remains vastly underdiagnosed. This lack of recognition is alarming, given that untreated FH patients face a 20-fold increased risk of early coronary heart disease. This article aims to provide a comprehensive overview of FH, covering its diagnosis, treatment, and the latest advancements in managing this condition to promote heart health.

How is Familial Hypercholesterolemia Diagnosed?

Familial Hypercholesterolemia Family Tree

Diagnosing FH involves a multifaceted approach that combines clinical evaluation, family history, and, in some cases, genetic testing. Early detection is key to preventing the long-term consequences of elevated LDL-C. Key factors considered in the diagnosis include:

A thorough physical examination is essential, looking for physical signs of high cholesterol. Family history of premature heart disease is a critical indicator. Lipid profile testing is also essential. Clinical diagnostic tools play a vital role in assessing the probability of FH. Also, the following criteria are important to consider:

  • Elevated LDL-C Levels: Persistently high LDL-C levels are a hallmark of FH. Adults with LDL-C levels ≥190 mg/dL and children with levels ≥160 mg/dL should be suspected of having FH.
  • Family History of Premature Coronary Artery Disease (CAD): A family history of heart attacks, strokes, or angina at a young age (before 55 in men and 60 in women) raises the likelihood of FH.
  • Physical Signs: Tendon xanthomas (cholesterol deposits in tendons, especially in the Achilles and hand tendons) and corneal arcus (a whitish ring around the cornea) are physical signs that can suggest FH.
  • Clinical Scoring Systems: Validated clinical tools such as the US MEDPED (Make Early Diagnosis Prevent Early Death), Dutch Lipid Clinic Network, and Simon Broome Registry criteria help quantify the likelihood of FH based on clinical and family history data.
While not always necessary for diagnosis, genetic testing can confirm FH by identifying mutations in genes like the LDLR gene. Genetic screening can be particularly useful in cascade screening, where family members of an affected individual are tested to identify other cases of FH. Data shows improved sensitivity of a genetic diagnosis compared to one based on epidemiologic LDL distributions. It's important to start cascade screening on all first-degree relatives if an accurate diagnosis of FH is made.

The Future of FH Management

The landscape of FH treatment is rapidly evolving, offering hope for better management and improved outcomes. Novel therapies and increased awareness promise to transform the lives of individuals and families affected by this condition. By staying informed and proactive, those with FH can take control of their heart health and live longer, healthier lives.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.15420/ecr.2014.9.2.76, Alternate LINK

Title: Current Treatment Of Familial Hypercholesterolaemia

Subject: Cardiology and Cardiovascular Medicine

Journal: European Cardiology Review

Publisher: Radcliffe Group Ltd

Authors: Cameron T Lambert, Pratik Sandesara, Ijeoma Isiadinso, Maria Carolina Gongora, Danny Eapen, Neal Bhatia, Jefferson T Baer, Laurence Sperling

Published: 2014-01-01

Everything You Need To Know

1

What exactly is Familial Hypercholesterolemia (FH)?

Familial Hypercholesterolemia (FH) is a genetic disorder that causes high levels of low-density lipoprotein cholesterol (LDL-C) from birth. This elevated LDL-C can lead to premature atherosclerotic cardiovascular disease (ASCVD), increasing the risk of heart attacks and strokes at a young age. Understanding FH is vital because early diagnosis and treatment can significantly improve health outcomes.

2

How do doctors typically diagnose Familial Hypercholesterolemia (FH)?

FH is typically diagnosed through a combination of methods. Doctors consider elevated LDL-C levels, a family history of premature coronary artery disease (CAD), and the presence of physical signs such as tendon xanthomas or corneal arcus. Clinical scoring systems like the US MEDPED, Dutch Lipid Clinic Network, and Simon Broome Registry criteria are also used to assess the likelihood of FH. Genetic testing can confirm the diagnosis by identifying mutations in genes like the LDLR gene. Cascade screening of first-degree relatives is recommended after an accurate diagnosis of FH.

3

What causes Familial Hypercholesterolemia (FH)?

Mutations in genes that regulate cholesterol processing, especially the LDL receptor (LDLR) gene, cause FH. These mutations impair the liver's ability to remove LDL-C from the blood, leading to its accumulation. There are two main types of FH: heterozygous FH (HeFH), where one copy of the affected gene is inherited, and homozygous FH (HoFH), where both copies are affected. HoFH is much rarer and more severe than HeFH.

4

How high do LDL-C levels typically get with Familial Hypercholesterolemia (FH)?

High LDL-C levels are a hallmark of FH. In adults, LDL-C levels of 190 mg/dL or higher should raise suspicion of FH, while in children, levels of 160 mg/dL or higher are concerning. Consistently elevated LDL-C from a young age significantly increases the risk of developing atherosclerotic cardiovascular disease (ASCVD).

5

How does genetic testing play a role in diagnosing Familial Hypercholesterolemia?

Genetic testing can confirm a diagnosis of FH by identifying mutations in genes like the LDLR gene. It is particularly useful in cascade screening, where family members of an affected individual are tested to identify other cases of FH. Early identification of affected individuals through genetic testing enables timely intervention and management to reduce the risk of cardiovascular events.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.